Study of the safety and therapeutic efficacy of multipotent adult progenitor cells in the treatment of perianal fistula in dogs
DOI:
https://doi.org/10.33448/rsd-v13i8.44682Keywords:
Stem cells; Perianal fistula; Cellular therapy; Security; Efficiency.Abstract
Perianal fistula is a conical, progressive, and painful inflammatory lesion that presents with ulceration in the anal and perianal regions. Current treatments consist of cleaning the area and analgesics or a surgical approach. Currently, stem cell therapy has been used successfully in the treatment of various diseases that affect small and large animals. The aim of this study was to evaluate the safety and efficacy of multipotent adult progenitor cell therapy in the treatment of perianal fistula in dogs. In the present study, twelve dogs were selected that had a perianal fistula for at least six months, and were refractory to treatment with cyclosporine A. The patients underwent cell transplantation with allogeneic stem cells to determine their safety and therapeutic efficacy. The results obtained demonstrated that this new methodology can result in the recovery of patients' quality of life.
References
Asai M & Sturion M (2014). Fístula perianal em cães – Revisão de literatura Medvep Dermato - Revista de Educação Continuada em Dermatologia e Alergologia Veterinária; 3(11), 366-369.
Assis, T. L. S., Winck, C. P. & Santos, E. J. C. (2017). Análise da Viabilidade Terapêutica das Células-Tronco Mesenquimais Alogênicas no Tratamento de Felino Acometido por Complexo Gengivite Estomatite Felina. Revista Científica Multidisciplinar Núcleo do Conhecimento. 2(1), 470-482.
Black, L. L., Gaynor, J., Gahring, D., Adams, C., Aron, D., Harman, S., Gingerich, D. A. & Harman, R. (2007). Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial. Vet Ther. Winter; 8(4), 272-84.
Berger D. R., Aune E. T., Centeno C. J. & Steinmetz N. J. (2020). Cryopreserved bone marrow aspirate concentrate as a cell source for the colony-forming unit fibroblast assay. Cytotherapy, 22(9), 486–493.
Cain C. L. (2019). Canine Perianal Fistulas: Clinical Presentation, Pathogenesis, and Management. The Veterinary clinics of North America. Small animal practice, 49(1), 53–65.
Cristóbal, J. I., Duque, F. J., Usón-Casaús, J. M., Ruiz, P., Nieto, E. L., & Pérez-Merino, E. M. (2021). Effects of Allogeneic Mesenchymal Stem Cell Transplantation in Dogs with Inflammatory Bowel Disease Treated with and without Corticosteroids. Animals (Basel). 11(7), 2061.
Doust R., Griffiths L. G. & Sullivan M. (2002). Evaluation of once daily treatment with cyclosporine for anal furunculosis in dogs. The Veterinary Record, 152:225–229.
Elkins, A. D. (2008). Canine perianal fistula – medical approach. NAVC Clinicians Brief, 14-16.
Ellison G. W. (1995). Treatment of perianal fistulas in dogs. J Am Vet Med Assoc. 206(11), 1680-2.
Ettinger, S. J. & Feldman, E. C. (2004). Tratado de medicina interna veterinária moléstias do cão e do gato. Guanabara Koogan, 2, 1335-1336.
Ferrer L., Kimbrel E. A., Lam A., Falk E. B., Zewe C., Juopperi T., Lanza R. & Hoffman A. (2016). Treatment of perianal fistulas with human embryonic stem cell-derived mesenchymal stem cells: a canine model of human fistulizing Crohn's disease. Regen Med. 11(1):33-43.
Hardie R. J., Gregory S. P., Tomlin J., Sturgeon C., Lipscomb V. & Ladlow J. (2005). Cyclosporine treatment of anal furunculosis in 26 dogs. J. Small Anim. Pract. 46:3–9.
Harvey, R & Horton, H (2023). Successful treatment of perianal fistulas in two dogs with oclacitinib. Veterinary Dermatology. 34(5), 483-486.
House A. K., Guitian J., Gregory S. P. & Hardie R. J. (2006). Evaluation of the Effect of Two Dose Rates of Cyclosporine on the Severity of Perianal Fistulae Lesions and Associated Clinical Signs in Dogs. Vet. Surg. 35:543–549.
Mathews K. A. & Sukhiani H. R. (1997). Randomized controlled trial of cyclosporine for treatment of perianal fistulas in dogs. J Am Vet Med Assoc. 211(10):1249-53.
Mendes, A. B. S., Silva, A. T. S., Castro, L. L., Silva, K. E. A. & Araripe, M. G. A. (2021). Therapeutic potential of mesenchymal stem cells in equine laminitis. Research, Society, and Development. 10 (10): e436101018902.
Mukhamedshina, Y., Shulman, I., Ogurcov, S., Kostennikov, A., Zakirova, E., Akhmetzyanova, E., Rogozhin, A., Masgutova, G., James, V., Masgutov, R., Lavrov, I., & Rizvanov, A. (2019). Mesenchymal Stem Cell Therapy for Spinal Cord Contusion: A Comparative Study on Small and Large Animal Models. Biomolecules, 9(12), 811.
Sancho, M. G., Sainz, A. & Franco, F. R. (2009). Aplicación de ciclosporina a diferentes dosis en el tratamiento de fístulas perianales en el perro. Madri: Clínica Veterinaria de Pequeños Animales, 29(3), 147- 153.
Santos, E. J. C. (2018a). Biologia das células-tronco mesenquimais de felinos obtidas a partir de nichos presentes no tecido adiposo objetivando sua aplicação terapêutica na medicina veterinária. Revista Eletrônica Científica da UERGS, 4(3), 368–379.
Santos, E. J. C., Poppi, F. P. & Braga, C. L. (2018b). Células progenitoras adultas multipotentes alogênicas no tratamento de doença renal em felinos. Science and Animal Health, 6(3), 266-285.
Santos, E. J. C., Winck, C. P., Alves, C. A. M. & Fernande, R. A. (2019a). Células-tronco mesenquimais alogênicas no tratamento das sequelas neurológicas de cinomose canina. Medvep - Revista Científica de Medicina Veterinária. Pequenos Animais e Animais de Estimação, 3(49), 32-40.
Santos, E. J. C., Winck, C. P., & Braga, C. L. (2019b). Utilização terapêutica das células progenitoras adultas multipotentes alogênicas em cães acometidos pela doença renal. Medicina Veterinária (UFRPE), 13(4), 534–543.
Santos, E. J. C. (2023a). Aplicação terapêutica das células-tronco na medicina veterinária. Núcleo do Conhecimento.
Santos E. J. C., Mazzeo, A. & Braga, C. L (2023b) Potencial terapêutico de células progenitoras adultas multipotentes alogênicas no tratamento de aplasia medular secundária à erliquiose canina, Science and Animal Health, 11(1), 35-52.
Santos, E. J. C.; Mazzeo, A. & Braga, C. L. (2024a). Study of the safety and therapeutic efficacy of multipotent adult progenitor cells in the treatment of feline asthma. Research, Society and Development, 13(3), e2713340644.
Santos, E. J. C., Mazzeo, A., & Braga, C. L. (2024b). Evaluation of the safety and therapeutic efficacy of multipotent adult progenitor cells in the treatment of canine bronchitis. Research, Society and Development, 13(4), e12713441499.
Smith R. K. & Webbon P. M. (2005). Harnessing the stem cell for the treatment of tendon injuries: heralding a new dawn? Br J Sports Med. 39(9):582-4.
Stanley B. J. & Hauptman, J. G. (2009). Prospective evaluation of long-term topical application of 0.1 % tacrolimus ointment for the treatment of perianal sinuses in dogs. Michigan: American Veterinary Medical Association, 235(4), 397-404.
Pieper, J. & Mckay, L. (2011). Compendium perianal fistulas. Vetleam.com: Compendium: Education for Veterinarians,
Villatoro, A. J., Fernández, V., Claros, S., Rico-Llanos, G. A., Becerra, J., & Andrades, J. A. (2015). Use of adipose-derived mesenchymal stem cells in keratoconjunctivitis sicca in a canine model. BioMed research international, 527926.
Villatoro, A. J., Hermida-Prieto, M., Fernández, V., Fariñas, F., Alcoholado, C., Rodríguez-García, M. I., Mariñas-Pardo, L., & Becerra, J. (2018). Allogeneic adipose-derived mesenchymal stem cell therapy in dogs with refractory atopic dermatitis: clinical efficacy and safety. The Veterinary Record, 183(21), 654.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Enrico Jardim Clemente Santos; Angela Mazzeo; Fernanda Simões Barna; Camila Landim Braga
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
